High dose chemotherapy with autologous stem cell support in patients with malignant diseases;Hoydosebehandling med autolog stamcellestotte hos kreftpasienter

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 13, 2000, Pages 1523-1528

  Abrahamsen, Jenny Foss ^b   Kristoffersen, Einar K ^b   Hervig, Tor ^b   Ekanger, Roald ^b   Nesthus, Ingerid ^b   Ulvestad, Elling ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOGUAZONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOGRAFT; BONE MARROW CELL; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHODGKIN LYMPHOMA; NORWAY; RELAPSE; STEM CELL TRANSPLANTATION; ADOLESCENT; AUTOTRANSPLANTATION; BREAST TUMOR; DOSE RESPONSE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LYMPHOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; NEOPLASM; PROGNOSIS; SARCOMA; STEM CELL MOBILIZATION; TESTIS TUMOR;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS; PROGNOSIS; SARCOMA; TESTICULAR NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034690501     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Høydosebehandling med perifer stamcellestøtte ved maligne lidelser. Helsedirektoratets utredningsserie I-95. Oslo: Statens helsetilsyn, 1995.
2. Kolstad A, Holte H, Kvaløy G, Jakobsen E, Erikstein B, Aurlien E et al. Høydosebehandling med autolog stamcellestøtte ved malignt lymfom og cancer mammae. Tidsskr Nor Lægeforen 1996; 116: 2547-51.
3. Aurlien E, Holte H, Pharo A, Jakobsen E, Smeland EB, Kvalheim G. Combination chemoterapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkins and non-Hodgkins lymphoma. Bone Marrow Transplant 1998; 21: 873-8.
4. Husebekk A, Kolstad A, Dahl IMS, Skogen B. Regionalisert høydose cellegiftbehandling med autolog stamcellestøtte. Tidsskr Nor Lægeforen 1998; 118: 2777-80.
5. Johnsen HE. Report from a Nordic workshop on CD34-positive cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories. J Hematother 1995; 4: 21-8.
6. Watts MJ, Sullivan AM, Leverett D, Peniket AJ, Perry AR, Williams CD et al. Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem cell mobilization. J Clin Oncol 1998; 16: 1554-60.
7. Gazitt Y, Freytes CO, Callander N, Tsai TW, Anderson AJ, Holle L et al. Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization. J Hematother 1999; 8: 173-83.
8. Bensinger W, Appelbaum F, Rowley S, Storb S, Sanders J, Lilleby K et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-55.
9. Begley CG, Basser R, Mansfield R, Thomson B, Parker WR, Layton J et al. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans. Blood 1997; 90: 3378-89.
10. Srour EF, Abonour R, Cornetta K, Traycoff CM. Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet? J Hematother 1999; 8: 93-102.